Racial differences in the prevalence of hypertensive retinopathy

Hypertension

Volumn 41, Issue 5, 2003, Pages 1086-1091

  Wong, Tien Yin ^a   Klein, Ronald ^b   Duncan, Bruce B ^c   Nieto, F Javier ^d   Klein, Barbara E K ^b   Couper, David J ^e   Hubbard, Larry D ^b   Sharrett, A Richey ^f  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e University of North Carolina at Chapel Hill   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Blacks; Blood pressure; Hypertension, genetic; Microcirculation; Race; Retinopathy

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY INTIMA PROLIFERATION; ARTICLE; COMMON CAROTID ARTERY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION RETINOPATHY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEGRO; PHOTOGRAPHY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RETINAL DISEASES; RISK FACTORS; UNITED STATES;

EID: 0037658916     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000064181.63546.53     Document Type: Article

References (33)

1. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study. Arch Intern Med. 1989;149:780-788.
2. Klag MJ, Whelton PK, Coresh J, Grim CE, Kuller LH. The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA. 1991;265:599-602.
3. Gillum RF. Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences. Hypertension. 1979;1:468-475.
4. Arnett DK, Rautaharju P, Crow R, Folsom AR, Ekelund LG, Hutchinson R, Tyroler HA, Heiss G. Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study). Atherosclerosis Risk in Communities. Am J Cardiol. 1994;74:247-252.
5. Alexander M, Grumbach K, Selby J, Brown AF, Washington E. Hospitalization for congestive heart failure. Explaining racial differences. JAMA. 1995;274:1037-1042.
6. Perneger TV, Klag MJ, Feldman HI, Whelton PK. Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA. 1993;269:1272-1277.
7. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African American and white men. 16-year MRFIT findings. JAMA. 1997;277:1293-1298.
8. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis. 1988;12:285-290.
9. Kittner SJ, White LR, Losonczy KG, Wolf PA, Hebel JR. Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA. 1990;264:1267-1270.
10. Otten MW Jr, Teutsch SM, Williamson DF, Marks JS. The effect of known risk factors on the excess mortality of black adults in the United States. JAMA. 1990;263:845-850.
11. Tso MOM, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology. 1982;89:1132-1145.
12. Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard LD, Nieto FJ. Retinal microvascular abnormalities and their relations with hypertension, cardiovascular diseases and mortality. Surv Ophthalmol. 2001;46:59-80.
13. Schneckloth RE, Stuart KL, Moore FE. Arterial pressure and hypertensive disease in a West Indian Negro population: report of a survey in St Kitts, West Indies. Am Heart J. 1962;63:607-628.
14. Ladipo GOA. Hypertensive retinopathy in Nigerians: a prospective clinical study of 350 cases. Trop Geogr Med. 1981;33:311-316.
15. McDonough JR, Garrison GE, Hames CG. Blood pressure and hypertensive disease among Negroes and whites. Ann Intern Med. 1964; 61(suppl 6):208-228.
16. Sharp PS, Chaturvedi N, Wormald R, McKeigue PM, Marmot MG, Young SM. Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension. 1995;25:1322-1325.
17. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet. 1989;1:1103-1106.
18. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
19. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106:2269-2280.
20. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, Wofford MR, Sharrett AR. Retinal microvascular abnormalities and incident strokes. The Atherosclerosis Risk in the Communities Study. Lancet. 2001;358:1134-1140.
21. Couper DJ, Klein R, Hubbard LD, Wong TY, Sorlie PD, Cooper LS, Brothers RJ, Nieto FJ. Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in the Communities Study. Am J Ophthalmology. 2002;133:78-88.
22. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities Study. Operations Manual No. 2, Cohort Component Procedures, Version 2.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1988.
23. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936-942.
24. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH. Cerebral white matter lesion, retinopathy and risk of clinical stroke: the Atherosclerosis Risk in the Communities Study. JAMA. 2002;288:67-74.
25. Palmer RS, Loofbourow D, Doering CR. Prognosis in essential hypertension: eight-year follow-up study of 430 patients on conventional medical treatment. N Engl Med J. 1948;239:990.
26. Breslin DJ, Gifford RW Jr, Fairbairn JF II, Kearns TP. Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA. 1966;195:335-338.
27. Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Sixth Report. Bethesda, Md: National Institutes of Health Publication 98-4080; 1997.
28. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russell G. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ. 1999;319:630-635.
29. Murray RF Jr. Skin color and blood pressure. Genetics or environment? JAMA. 1991;265:639-640.
30. Devereux RB, Okin PM, Roman MJ. Pre-clinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damage independent of blood pressure? Ethn Dis. 1998;8:138-148.
31. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648-655.
32. Ryu JE, Murros K, Espeland MA, Rubens J, McKinney WM, Toole JF, Crouse JR. Extracranial carotid atherosclerosis in black and white patients with transient ischemic attacks. Stroke. 1989;20:1133-1137.
33. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke. 1993;24:1297-1304.